Vaccine manufacturer Novavax Inc. has announced the shipment of millions of doses of its updated COVID-19 vaccines to distributors following approval from U.S. regulators.
Vaccine maker Novavax Inc on Monday said it has shipped millions of doses its updated COVID-19 shots to distributors after receiving the go-ahead from U.S. regulators. The U.S. Food and Drug Administration authorized the updated vaccine last week for emergency use in individuals aged 12 years and older, but batches of the shots needed additional clearance from the FDA before they could be released. Novavax said it expects the shots to be available at U.S. pharmacies this week.
I'M HELPING DOCTORS TAKE FDA TO COURT OVER DANGEROUS DRUGS THAT KILL WOMEN CLICK HERE TO GET THE FOX NEWS APP The Maryland-based company, whose COVID vaccine is its lone marketed product, has adopted cost-cutting measures and is counting on commercial sales of its updated shot to help it stay afloat. The company has said it may not be able to remain solvent otherwise.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Commercialization Is Making Access to the New COVID Vaccine More DifficultAs health care inequities deepen, pharmaceutical giants and insurers are maximizing profits.
Lire la suite »
Health officials seeing insurance barriers for new COVID vaccineThe Cleveland Department of Public Health (CDPH) is warning of barriers that could keep people from getting the new COVID vaccine, now that we are no longer in a “public health emergency.”
Lire la suite »
FDA-approved injection can restore collagen and improve aging signsThe Food and Drug Administration has approved an easy and effective method of restoring collagen in the skin without having to ingest endless supplements.
Lire la suite »
Alnylam to scrap sNDA for patisiran after receiving FDA complete response letterCiara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Lire la suite »
Alnylam Stock Is Dropping on Surprising FDA RejectionDrugmaker Alnylam wanted to expand approval of its drug Onpattro, but the Food and Drug Administration rejected the application even after an outside...
Lire la suite »
FDA Adds Warning To Ozempic Label About Ileus, Intestinal BlockageI am a writer, journalist, professor, systems modeler, computational, AI, and digital health expert, medical doctor, avocado-eater, and entrepreneur, not always in that order. Currently, I am a Professor of Health Policy and Management at the City University of New York (CUNY) School of Public Health, Executive Director of PHICOR (PHICORteam) and Center for Advanced Technology and Communication in Health (CATCH), and founder and CEO of Symsilico. My previous positions include serving as Profess
Lire la suite »